Covaxin shows 77.8 % efficacy in phase 3 trial data in review by subject expert committee (SEC): Sources
The post Covaxin shows 77.8 % efficacy in phase 3 trial data in review by subject expert committee (SEC): Sources appeared first on KalingaTV.
Please follow and like us:
